Neogenomics Inc
NASDAQ:NEO

Watchlist Manager
Neogenomics Inc Logo
Neogenomics Inc
NASDAQ:NEO
Watchlist
Price: 15.83 USD 0.06% Market Closed
Market Cap: 2B USD
Have any thoughts about
Neogenomics Inc?
Write Note

Neogenomics Inc
Research & Development

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Neogenomics Inc
Research & Development Peer Comparison

Comparables:
TMO
DHR
MTD
A
IQV

Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
Neogenomics Inc
NASDAQ:NEO
Research & Development
-$27.9m
CAGR 3-Years
-40%
CAGR 5-Years
-43%
CAGR 10-Years
-30%
Thermo Fisher Scientific Inc
NYSE:TMO
Research & Development
-$1.3B
CAGR 3-Years
1%
CAGR 5-Years
-6%
CAGR 10-Years
-8%
Danaher Corp
NYSE:DHR
Research & Development
-$1.4B
CAGR 3-Years
4%
CAGR 5-Years
-8%
CAGR 10-Years
-3%
Mettler-Toledo International Inc
NYSE:MTD
Research & Development
-$184.7m
CAGR 3-Years
-6%
CAGR 5-Years
-5%
CAGR 10-Years
-4%
Agilent Technologies Inc
NYSE:A
Research & Development
-$456m
CAGR 3-Years
-2%
CAGR 5-Years
-2%
CAGR 10-Years
-20%
IQVIA Holdings Inc
NYSE:IQV
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Neogenomics Inc's Research & Development?
Research & Development
-27.9m USD

Based on the financial report for Jun 30, 2024, Neogenomics Inc's Research & Development amounts to -27.9m USD.

What is Neogenomics Inc's Research & Development growth rate?
Research & Development CAGR 10Y
-30%

Over the last year, the Research & Development growth was 3%. The average annual Research & Development growth rates for Neogenomics Inc have been -40% over the past three years , -43% over the past five years , and -30% over the past ten years .

Back to Top